Active Pharmaceutical Ingredients Market Size to Reach USD

0

Pune, India, July 26. 2022 (GLOBE NEWSWIRE) — The world Active Pharmaceutical Ingredients (API) Market is expected to grow due to the increasing prevalence of infectious diseases and cancer. This would further increase the demand for APIs to develop unique drugs. The National Cancer Institute estimated that in 2018 about 1,735,530 new cases of cancer were diagnosed. Fortune Business Insights™ released this information in a recently released report titled, “Active Pharmaceutical Ingredients Market Size, Industry Share, and Analysis, By Type (Generic API and Branded API), By Synthesis (Biological API and synthetic) and Regional forecasts, 2021-2028. The report further states that the API market size was USD 174.17 Billion in 2021 and is projected to reach USD 272.44 Billion by 2028, growing at a CAGR of 6.6% during the forecast period. .

Industry developments:

  • March 2021 – Amgen confirmed the acquisition of Rodeo Therapeutics, a biopharmaceutical company focused on the development of small molecule therapies. The acquisition will allow Amgen to expand its portfolio of inflammation APIs.
  • February 2020: Sanofi has announced its intention to develop an autonomous organization which would be integrated into the first’s six European API production sites.

Request a sample copy of the research report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/active-pharmaceutical-ingredient-api-market-102656

Scope of the API Market Report

Report cover Details
Forecast period 2021 to 2028
Forecast Period 2021 to 2028 CAGR 6.6%
2028 value projection $272.44 billion
base year 2020
Market size in 2021 $174.17 billion
Historical data for 2017 to 2019
Number of pages 138

Drivers and Constraints-

Growing use of imported APIs to develop unique products will drive growth

The Indian Brand Equity Foundation (IBEF) announced that the Indian pharmaceutical industry is expected to grow at a CAGR of 22.4% during the period 2015-2020. After India, Chinese industry is considered the second largest. As the cases of chronic diseases are increasing rapidly day by day, there is a high demand and demand for organic products across the world. Moreover, in emerging countries, the use of imported APIs is growing to develop highly innovative biopharmaceutical products.

Several pharmaceutical companies in the world mainly focus on research and development activities to unveil cutting-edge drugs. However, frequent and unexpected changes in drug pricing policy, especially in developing countries of the world, might hamper the growth of the API market in the near future.

For more information Please visit: https://www.fortunebusinessinsights.com/active-pharmaceutical-ingredient-api-market-102656

Regional Analysis-

Presence of numerous pharmaceutical companies to foster growth in Asia-Pacific

Geographically, North America generated $79.80 billion in revenue in 2018. This growth is attributed to the increasing prevalence of chronic diseases in this region. Along with this, the growing government initiatives to develop innovative drugs would also contribute to the growth of the market here. Asia-Pacific, on the other hand, is expected to overtake Europe and North America with a high CAGR. This would occur mainly due to the growing number of pharmaceutical companies and contract manufacturing organizations in India and China.

Competitive landscape-

Major Players Focus on Developing New Drugs to Cure Chronic Diseases

The market is home to a large number of API manufacturers, such as Mylan, Teva, AbbVie, and others. They have a diverse product portfolio and extensive networks around the world. Most of them today focus on developing new drugs to cure cancer and other related diseases.

Quick Buy – Active Pharmaceutical Ingredients Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102656

Segment-

Synthetic API segment to dominate supported by its low cost of production

Based on synthesis, the market is divided into biological API and synthetic API. Among these, synthetic API segment is expected to dominate in terms of API market share. This growth is attributable to the low production cost of chemically synthesized APIs. The biologics API segment is expected to show a high growth rate in the coming years, supported by the increasing innovations in biologics to meet urgent medical needs.

Active Pharmaceutical Ingredients Market Segmentation By type
By synthesis
  • Biological API
  • Synthetic API
By geography
  • North America (by type, by synthesis and by country)
  • Europe (by type, by synthesis and by country/sub-region)
  • Asia-Pacific (by type, by summary and by country/sub-region)
  • Rest of the world (by type and by synthesis)

This report answers the following questions:

  • What is a Global Active Pharmaceutical Ingredient (API) in 2022?

Active Pharmaceutical Ingredients, i.e. APIs attributed to an active ingredient contained in the drug. For example, the active ingredient for pain relief is integrated into the analgesic. This is called the API. Even its small amount has a powerful impact, so only part of this active ingredient is contained in the drug. In addition, you will find its quantity and name contained in the drug on the packaging of over-the-counter drugs.

Medication elements

Every drug is made up of 2 basic elements, namely the active pharmaceutical ingredients which are the main ingredient, as well as the excipient, which are the non-drug substances that help deliver the drug to the system. Excipients are chemically inactive compounds, such as mineral oil or lactose in the medicine. API is not made by a single reaction from raw materials, but instead becomes API through various chemical compounds.

  • Which company would stay on top in the years to come?
  • Which segment should dominate in the future?

List of Key Players Covered in the Market Report

  • Teva Pharmaceutical Industries Ltd
  • AbbVie Inc.
  • Abbott
  • Aurobindo Pharmacy
  • Cipla inc.
  • Dr. Reddy’s Ltd Laboratories
  • Sun Pharmaceutical Industries Ltd
  • Amgen Inc.
  • Biocon
  • Mylan AG
  • Others

You have a question ? Ask our experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/active-pharmaceutical-ingredient-api-market-102656

Contents:

  • Global Market Analysis, Outlook and Forecast, 2015-2026
    • Main results/summary
    • Market Analysis, Outlook and Forecast – By Type
      • Generic Active Pharmaceutical Ingredient
      • Branded APIs
    • Market Analysis, Outlook and Forecast – By Summary
      • Biological API
      • Synthetic API
    • Active Pharmaceutical Ingredients Market Analysis, Outlook and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of the world
  • North America Industry Analysis, Outlook and Forecast, 2015-2026
    • Main results/summary
    • Market Analysis, Outlook and Forecast – By Type
    • Market Analysis, Outlook and Forecast – By Summary
      • Biological API
      • Synthetic API
    • Market Analysis, Outlook and Forecast – by Country
  • Europe Active Pharmaceutical Ingredients (API) Market Analysis, Outlook and Forecast, 2015-2026
    • Main results/summary
    • Market Analysis, Outlook and Forecast – By Type
    • Market Analysis, Outlook and Forecast – By Summary
      • Biological API
      • Synthetic API
    • Market analysis, outlook and forecast – by country/sub-region
      • UK
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia
      • The rest of Europe
  • Asia-Pacific Industry Analysis, Outlook and Forecast, 2015-2026
    • Main results/summary
    • Market Analysis, Outlook and Forecast – By Type
      • Generic Active Pharmaceutical Ingredient
      • Branded APIs
    • Market Analysis, Outlook and Forecast – By Summary
      • Biological API
      • Synthetic active pharmaceutical ingredient
    • Market analysis, outlook and forecast – by country/sub-region
      • Japan
      • China
      • India
      • Australia
      • South East Asia
      • Rest of Asia-Pacific
  • Rest of the World Market Analysis, Outlook and Forecast, 2015-2026
    • Main results/summary
    • Market Analysis, Outlook and Forecast – By Type
    • Market Analysis, Outlook and Forecast – By Summary
  • Competitive analysis
      • Biological API
      • Synthetic API
    • Key Developments in the Active Pharmaceutical Ingredients Market
    • Global Market Share Analysis (2018)
    • Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (as available))
      • Teva Pharmaceutical Industries Ltd
      • AbbVie Inc.
      • Abbott
      • Aurobindo Pharmacy
      • Cipla inc.
      • Dr. Reddy’s Ltd Laboratories
      • Sun Pharmaceutical Industries Ltd
      • Amgen Inc.
      • Biocon

Table of contents Continued…

Get your personalized research report: https://www.fortunebusinessinsights.com/enquiry/customization/active-pharmaceutical-ingredient-api-market-102656

About Us:

Fortune Business Insights™ provides accurate data and innovative business analytics, helping organizations of all sizes make the right decisions. We adapt innovative solutions to our clients, helping them to meet various challenges specific to their activities. Our goal is to give them holistic market intelligence, providing them with granular insight into the market they operate in.

Contact us:

Fortune Business Insights™ Pvt. ltd.

Pune – 411045, Maharashtra, India.

Call:

United States: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

E-mail: [email protected]

Share.

Comments are closed.